See All Slides - tctmd.com

Slides

Presentation TCT 2012

Recanalization of Aortoiliac CTOs: Access Strategies and the Value of Occlusion Devices

Presenter: John Laird Jr

October 23, 2012

Presentation TCT 2012

Overview 2: Biological Therapies for Heart Failure: Regulatory Perspectives

Presenter: Steve Winitsky

October 23, 2012

Presentation TCT 2012

Viability Testing, Clinical Decision Making(2)

Presenter: Issam Mikati

October 23, 2012

Presentation TCT 2012

TCT-61. Infarct Size-Determined Uptake of CD34+ Cells in the Peri-Infarct Zone and Left Ventricular Remodeling: Insights from Integration of Labeled Cells Uptake SPECT...

Presenter: Piotr Musialek

October 23, 2012

Presentation TCT 2012

Late Breaking Clinical Trials: BRIDGE-ACS (Multimodality Approach to Adherence), INFUSE-AMI (STEMI), and IMMEDIATE (GIK)

Presenter: Ajay Kirtane

October 23, 2012

Presentation TCT 2012

WATCHMAN Tips and Tricks

Presenter: Peter Sick

October 23, 2012

Presentation TCT 2012

Synergy (Boston Scientific) Program Update

Presenter: Ian Meredith

October 23, 2012

Presentation TCT 2012

TARGET I: A Prospective, Randomized Trial of a Biodegradable Polymer-based Sirolimus-Eluting Stent vs an Everolimus-Eluting Stent (MicroPort)

Presenter: Run-Lin Gao

October 23, 2012

Presentation TCT 2012

When Do I Prefer PCI for MVD? The Surgeon's Perspective

Presenter: A. Pieter Kappetein

October 23, 2012

Presentation TCT 2012

Appropriateness Criteria: Implications for Clinical Practice

Presenter: Monica Losquadro

October 23, 2012

Advertisement

Slides

Recanalization of Aortoiliac CTOs: Access Strategies and the Value of Occlusion Devices

Overview 2: Biological Therapies for Heart Failure: Regulatory Perspectives

Viability Testing, Clinical Decision Making(2)

TCT-61. Infarct Size-Determined Uptake of CD34+ Cells in the Peri-Infarct Zone and Left Ventricular Remodeling: Insights from Integration of Labeled Cells Uptake SPECT...

Late Breaking Clinical Trials: BRIDGE-ACS (Multimodality Approach to Adherence), INFUSE-AMI (STEMI), and IMMEDIATE (GIK)

WATCHMAN Tips and Tricks

Synergy (Boston Scientific) Program Update

TARGET I: A Prospective, Randomized Trial of a Biodegradable Polymer-based Sirolimus-Eluting Stent vs an Everolimus-Eluting Stent (MicroPort)

When Do I Prefer PCI for MVD? The Surgeon's Perspective

Appropriateness Criteria: Implications for Clinical Practice

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content